Bogle Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-37,648
Closed -$2.81M 354
2020
Q1
$2.81M Sell
37,648
-156,579
-81% -$10.8M 0.29% 100
2019
Q4
$12.6M Hold
194,227
1.18% 22
2019
Q3
$12.3M Hold
194,227
1.06% 32
2019
Q2
$13.1M Hold
194,227
1.03% 21
2019
Q1
$12.6M Buy
+194,227
New +$12.9M 0.97% 33
2017
Q4
Sell
-131,376
Closed -$10.6M 310
2017
Q3
$10.6M Buy
+131,376
New +$10M 0.72% 55
2017
Q2
Sell
-156,837
Closed -$10.7M 327
2017
Q1
$10.7M Buy
156,837
+4,731
+3% +$333K 0.74% 61
2016
Q4
$10.9M Buy
152,106
+7,688
+5% +$571K 0.75% 56
2016
Q3
$11.4M Buy
144,418
+200
+0.1% +$16.2K 0.82% 33
2016
Q2
$12M Buy
144,218
+15,900
+12% +$1.41M 0.83% 35
2016
Q1
$11.8M Buy
128,318
+29,400
+30% +$2.65M 0.79% 44
2015
Q4
$10M Sell
98,918
-6,082
-6% -$633K 0.72% 51
2015
Q3
$10.3M Buy
105,000
+24,000
+30% +$2.67M 0.73% 49
2015
Q2
$9.48M Buy
+81,000
New +$8.85M 0.71% 45
2015
Q1
Sell
-126,799
Closed -$12M 368
2014
Q4
$12M Buy
126,799
+1,600
+1% +$165K 0.79% 35
2014
Q3
$13.3M Buy
125,199
+2,500
+2% +$245K 0.86% 27
2014
Q2
$10.2M Buy
+122,699
New +$9.55M 0.68% 62

Other funds holding GILD

Bogle Investment Management's GILD Position: Q2 2020 in Review

Bogle Investment Management sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 37,648 shares — an estimated $2.81M sold.

Bogle Investment Management first reported a position in GILD in Q2 2014 and held it in 17 quarters. The position peaked at $13.3M in Q3 2014. 1,625 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Bogle Investment Management reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • Bogle Investment Management sold 37,648 Gilead Sciences shares in Q2 2020, an estimated $2.81M.
  • Bogle Investment Management first reported a position in Gilead Sciences in Q2 2014 and held it in 17 quarters.
  • Bogle Investment Management's Gilead Sciences position peaked at $13.3M in Q3 2014.
  • 1,625 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Bogle Investment Management's 13F filing for Q2 2020, filed 13 Aug 2020.